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ABSTRACT
The nuclear antisense properties of a series of tri-
cyclo (tc)-DNA oligonucleotide 9±15mers, targeted
against the 3¢ and 5¢ splice sites of exon 4 of cyclo-
philin A (CyPA) pre-mRNA, were evaluated in HeLa
cells and compared with those of corresponding
LNA-oligonucleotides. While the 9mers showed no
signi®cant antisense effect, the 11±15mers induced
exon 4 skipping and exon 3+4 double skipping to
about an equal extent upon lipofectamine mediated
transfection in a sequence- and dose-dependent
manner, as revealed by a RT±PCR assay. The anti-
sense ef®cacy of the tc-oligonucleotides was found
to be superior to that of the LNA-oligonucleotides in
all cases by a factor of at least 4±5. A tc-oligo-
nucleotide 15mer completely abolished CyPA mRNA
production at 0.2 mM concentration. The antisense
effect was con®rmed by western blot analysis which
revealed a reduction in CyPA protein to 13% of its
normal level. Fluorescence microscopic investiga-
tions with a ¯uorescein labeled tc-15mer revealed a
strong propensity for homogeneous nuclear local-
ization of this backbone type after lipofectamine
mediated transfection, while the corresponding lna
15mer showed a less clear cellular distribution
pattern. Transfection without lipid carrier showed
no signi®cant internalization of both tc- and LNA-
oligonucleotides. The obtained results con®rm the
power of tc-DNA for nuclear antisense applications.
Moreover, CyPA may become an interesting thera-
peutic target due to its important role in the early
steps of the viral replication of HIV-1.
INTRODUCTION
Antisense oligonucleotides that are stable against nucleolytic
degradation and that do not induce RNase H catalyzed
hydrolysis of complementary mRNA were shown to be
powerful modulators of pre-mRNA splicing in vitro and
in vivo (1,2). Such oligonucleotides have successfully been
used in the past to shift pre-mRNA splicing of CFTR (3),
IL-5R (4), c-myc (5), tau (6), SMN-2 (7), bcl-x (8±10),
b-globin (11,12) and dystrophin (13±15). Amongst the
oligonucleotide analogues most intensively investigated for
splice shifting are the anionic analogues 2¢-OMe-RNA and 2¢-
methoxyethyl (MOE)-RNA, as well as the charge neutral
analogues morpholino-DNA and PNA. A direct comparison of
the four different backbone types has recently been performed
in a in vitro assay in which the modi®ed oligonucleotides
blocked aberrant and restored correct splicing of modi®ed
enhanced green ¯uorescent protein (EGFP) pre-mRNA (16). It
was found that free uptake and the antisense ef®cacy of neutral
morpholino derivatives and of PNA carrying 4 C-terminal
lysine residues were signi®cantly higher than that of the
negatively charged 2¢-O-alkyl RNAs. Interestingly, the same
assay in a transgenic mouse model showed inverted results
with the 2¢-O-MOE oligonucleotides showing much higher
activity than the lysine modi®ed PNA or morpholino-
oligonucleotides.
High potential in terms of antisense properties is given to
the class of conformationally constrained oligonucleotide
analogues such as for example LNA (17,18) or tricyclo (tc)-
DNA (19) (Fig. 1), which show signi®cantly enhanced target
binding properties and enhanced biological stability. In the
case of LNA, ef®cient antisense activity was reported for a
G-protein coupled receptor in rat brain (20), HIV-1 TAR (21),
VR1 (22,23) and human telomerase (24). Given the fact that
both backbone systems do not mediate RNaseH activity, they
seem particularly well suited for nuclear antisense applica-
tions. We recently investigated tc-DNA for correction of
aberrant b-globin splicing in a cellular assay and found a 100-
fold increased antisense activity relative to 2¢OMe-PS-RNA
(25). In order to compare the nuclear antisense properties of
the two backbone systems we set out to study their perform-
ance side by side in a cyclophilin A (CyPA) splice assay.
We chose CyPA because of recent data, suggesting it to be a
target for the inhibition of HIV-1 replication. CyPA is a
proline cis±trans isomerase that was initially discovered as the
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cellular ligand of the immunosuppressive drug cyclosporin A
(CsA) (26). Although CyPA has been implicated in diverse
functions such as for example in the heat-shock response (27),
in the nuclear import of some proteins (28), and in various
signal transduction pathways (29,30), its exact function is still
not yet fully understood. Surprisingly, it was shown that CyPA
was speci®cally incorporated into HIV-1 virions and was
required to maintain ef®cient viral replication (31±34).
Virions lacking CyPA show normal morphologies, package
normal levels of viral proteins and RNAs, and exhibit normal
reverse transcriptase activity (31,35). However, the viral
replication is blocked at some step after viral entry but before
the reverse transcription starts (31). More recently, it was
shown that CyPA might also function at the viral entry step of
HIV-1 infection (36,37). Taken together, these observations
imply that CyPA not only participates in post-entry events,
but also contributes to the early events of HIV-1 replication
(36±38).
We found that tc-oligonucleotides, 11±15 nt in length,
targeted to the 3¢-splice site of exon 4 of the CyPA pre-mRNA
ef®ciently redirect splicing by skipping exon 3 and 4
simultaneously in a dose-dependent manner. Down-regulation
of CyPA was con®rmed by western blot analysis. In the given
assay, tc-DNA outperformed LNA in antisense ef®cacy.
Intracellular distribution of a 3¢-¯uorescein labeled tc-
oligonucleotide 15mer in HeLa cells after lipofection revealed
selective accumulation of the oligonucleotide in the nucleus
which might be a reason for the observed strong nuclear
antisense effect.
MATERIALS AND METHODS
Synthesis and puri®cation of oligonucleotides
Tc-oligonucleotides (Table 1) were prepared on the 0.2 and
1.3 mmol scale on a PerSeptive Biosystems Expedite or on a
Pharmacia Gene Assembler SpecialÔ DNA-synthesizer using
the modi®ed phosphoramidite chemistry procedure as re-
ported previously (19). The oligomers tc1 and tc2 were
synthesized on universal solid support (GlenResearch). The
oligomers tc3±tc5 were assembled on a universal solid support
(CT-Gen, San Jose, CA). The 3¢-¯uorescein-labeled oligomer
tc6 was synthesized on the 1.3 mmol scale using LC
¯uorescein CPG (Roche Diagnostics). All tc-oligomers were
synthesized with an additional nucleotide unit at its 5¢ end
which is cleaved during deprotection, resulting in a 5¢-terminal
phosphate group (39). The coupling time was set to 10 min,
and 5-(ethylthio)-1H-tetrazole (0.25 M in CH3CN) was used
as activator. Coupling yields were >95% per step.
Deprotection and cleavage from the solid support were
performed under standard conditions (conc. NH3, 16±60 h,
55±65°C). The molecular compositions of all oligonucleotides
were determined by ESI± mass spectrometry (Table 1). The
experimental masses of tc1 and tc2 showed the presence of a
3¢-terminal 2,5-dimethoxytetrahydrofuran-3,4-diol unit aris-
ing from the universal solid support. Oligonucleotide tc-NS
had already been synthesized before and was used in the
present study as a nonsense-sequence (25). LNA phosphor-
amidites with the bases adenine, thymine, guanine and
5-methylcytosine were purchased from Exiqon. The LNA
oligonucleotides were prepared on the 1.3 mmol scale on a
Pharmacia Gene Assembler SpecialÔ DNA-synthesizer
according to the manufacturer's protocol on either universal
solid support from CT-Gen (lna1±lna5) or on LC ¯uorescein
CPG (lna6). Crude oligonucleotides were puri®ed by DEAE
ion exchange HPLC and/or reversed phase HPLC.
Oligonucleotide tc6 was prepuri®ed by gel ®ltration over
Sephadex G-25 and then puri®ed by reversed phase HPLC.
Also in these cases the compositions of the oligonucleotides
were con®rmed by ESI-MS (Table 1).
Cell culture, transfection and analysis
HeLa cells were grown in Dulbecco's modi®ed Eagle's
medium supplemented with 10% fetal calf serum, 100 U/ml
penicillin and 100 mg/ml streptomycin at 37°C in an incubator
containing 5% CO2. For transfection, 2.5 3 105 HeLa cells
were seeded in a six-well plate. After 12 h, 0.05, 0.1 or 0.2 mM
of oligonucleotides (®nal concentration in 1 ml of transfection
solution) were complexed with 1.5, 3 or 6 ml LipofectAMINE
(Invitrogen/Life Technologies), respectively in 0.2 ml of
OptiMEM (Invitrogen/Life Technologies) at room tempera-
ture for 30 min. Then the complex was diluted with OptiMEM
to a ®nal volume of 1 ml and added to the cells for further
incubation. The medium was replaced by normal growth
medium after 5 h.
TRI-Reagent Kit (MRC, Cincinnati, OH) was used for total
RNA isolation, and the RNA was usually isolated 48 h after
transfection. To detect CyPA mRNA, 250 ng of total RNA
was analyzed by RT±PCR using rTth DNA polymerase
(Applied Biosystems) in a ®nal volume of 50 ml with forward
and reverse primers corresponding to the sequences of exon 1
and exon 5, respectively. CyPA 5¢-primer: (1671±1690, CyPA
exon 1): 5¢-CACCGTGTTCTTCGACATTG; 3¢-primer:
(6260±6279, CyPA exon 5), 5¢-CCATGGCCTCCACAA-
TATTC. The reverse transcribed CyPA mRNA was ampli®ed
with 32P-labeled dCTP for 31 cycles (94°C for 1 min, 60°C for
1 min, 72°C for 10 min). The RT±PCR products were
separated on 6% non-denaturing polyacrylamide gels. Dried
gels were exposed to storage phosphor screens (Molecular
Dynamics) and visualized with the AIDA program (version
2.31, Raytest IsotopenmessgeraÈte GmbH, Straubenhardt,
Germany). Data were analyzed using ImageQuant software
(version 3.3).
Western blot
HeLa cells were transfected with oligonucleotide tc4. After
72 h, the cells were lysed in SDS sample buffer and separated
by 12% SDS±PAGE. The gel was transferred to a nitro-
cellulose membrane overnight. Polyclonal rabbit anti-human
Figure 1. Molecular structures of tc-DNA and LNA in comparison to DNA.
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CyPA- (1:1000, gift from Dr Uta Vonschwedler, University of
Utah) or anti-actin- (Sigma, 1:500) antibodies were used as the
®rst antibodies, and anti-rabbit horseradish peroxidase-linked
antibody (Promega, 1:2500) as the secondary antibody.
Detection was carried out using the ECL chemiluminescence
technique (Amersham Pharmacia) and the blot was exposed to
an AGFA X-ray ®lm. The protein level was quanti®ed with
ImageQuant software (version 3.3). The signals were cor-
rected to the actin loading level.
Cellular uptake and microscopy
HeLa cells were cultured and transfected with 0.2 mM (®nal
concentration) of ¯uorescein labeled oligonucleotide tc6 or
lna6, complexed with 6 ml lipofectAMINE as described
before, and analyzed after 24 h by ¯uorescence microscopy
(Leica Microsystems, Leica TCS SP2; microscope: Leica DM
IRE2). For transfection without lipofectamine, HeLa cells
were cultured and treated with a 20 mM solution of tc6 or lna6
in DMEM+/+ medium at 37°C for 24 h. The cells were then
washed twice with PBS solution, and fresh DMEM+/+ was
added. The living cells were ®rst analyzed by ¯uorescence
microscopy and then counted with a ¯uorescence activated
cell sorter (FACS).
RESULTS
Design of oligonucleotides and general splicing pattern
We decided to investigate the modi®cation of CyPA pre-
mRNA splicing patterns in HeLa cell cultures using
oligonucleotides that were targeted to the 3¢- or 5¢-splice
sites of exon 4 (Table 1).
More precisely, sequences complementary to the 5¢-splice
site between exon 4 and intron 4 were used to compare the
ef®cacy, minimal length requirements and mismatch sensitiv-
ity of tc- and LNA-oligonucleotides (tc1±5 and lna1±5). The
3¢-splice site between intron 3 and exon 4 was the target of tc6
and lna6 which were 3¢-¯uorescein (FAM) labeled. This
sequence was primarily used to follow cellular uptake and
distribution. In all cases, we observed a general splicing
pattern in which skipping of exon 4 and double skipping of
exons 3+4 occurred on the mRNA level. A schematic
representation of the redirection of CyPA pre-mRNA splicing
in the presence of antisense oligonucleotides is given in
Figure 2.
Thermal stability of tc- and LNA oligonucleotides with
complementary RNA
Thermal stabilities of duplexes with the RNA 17mer repre-
senting the 5¢-splice site of CyPA pre-mRNA were assessed by
UV-melting curve analysis, and the corresponding Tms are
listed in Table 1. The Tms of tc1±4 range from 56 to 83°C. The
mismatched 15mer tc5 shows a decrease in thermal stability
relative to the matched 15mer tc4 by 23°C. Its thermal stability
is thus between that of the matched 9- and 11mer (tc1 and tc2).
The corresponding oligonucleotides with the LNA backbone
bind signi®cantly more ef®ciently to the corresponding RNA
target. While lna1 shows a Tm of 82.6°C, that of lna2 was
already at 95°C. For lna3 and lna4, no sigmoidal melting
curves could be observed indicating even higher Tms. The
mismatched 15mer lna5 showed a Tm of 92°C which lies in
between that of the 9mer lna1 and 11mer lna2, as in the case of
tc-DNA. Thus LNA binds RNA with comparable selectivity
but overall higher af®nity by ca. 2.5±3.0°C/per mod. relative
to tc-DNA. Whether the increase in af®nity of LNA is entirely
due to the backbone or arises in part by the base
5-methylcytosine used instead of cytosine remains open.
Antisense activity of tc-oligonucleotides
HeLa cells were transfected with three different concentra-
tions (0.05, 0.1 and 0.2 mM) of oligonucleotides tc1±5. After
48 h total RNA was isolated, ampli®ed by RT±PCR, and the
products separated by PAGE (Fig. 3). To obtain quantitative
data, we determined the residual full-length CyPA mRNA as a
fraction of total RNA (full length + exon skipped RNA) by
phosphor imaging (Fig. 4).
With the exception of tc1 (9mer), all oligonucleotides led to
a signi®cant amount of exon 4 skipping and exon 3+4 double
skipping. The degree of splice shifting increased with
increasing length and increasing dose of the antisense
oligonucleotides. At the lowest (50 nM) concentration inves-
tigated, essentially no antisense effect was observed for tc2
(11mer) while a reduction in full length RNA by ca. 10%
occurs for tc3 (13mer) and tc4 (15mer). At 0.1 mM concen-
tration of tc2, tc3 and tc4, full length RNA is reduced to 70%,
43% and 25%, respectively, relative to the control without
oligonucleotide. At 0.2 mM concentration, the level of full
length RNA was below 20% for tc2 and 3, and was essentially
undetectable in the case of tc4, indicating quantitative splice
shifting in the corresponding pre-mRNA. In all cases, the
bands corresponding to mRNA in which only exon 4 was
skipped were slightly more intense than that of exon 3+4
double skipping.
Sequence speci®city in the antisense response was inves-
tigated with oligonucleotide tc5, showing the same length as
tc4 but two mismatches in the center of the sequence. In this
case, we observed a reduction in full length RNA (Fig. 4) by
28% only at high (0.2 mM) concentration. Thus its antisense
activity lies between those of the matched 9- and 11mers and
is far inferior to that of the fully matched 15mer tc4. An
additional control with the non-sequence related oligonucleo-
tide tcNS showed no exon skipping at all by RT±PCR over the
same concentration range (data not shown).
From these results, we conclude that the observed change in
the splice pattern of CyPA pre-mRNA is due to a true
antisense effect of the oligonucleotide analogues.
Furthermore, a sequence length of 9 is insuf®cient for eliciting
Figure 2. Schematic representation of the splicing pattern of CyPA
pre-mRNA. The ball at tc6 or lna6 represents the ¯uorescein label.
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signi®cant antisense effects in the submicromolar range while
with 15, complete reorientation of splicing is achieved at
0.2 mM concentration.
The ¯uorescein labeled oligonucleotide tc5 targeted to the
3¢ splice site displayed an antisense activity comparable to
the oligonucleotides directed to the 5¢-splice site, displaying
the same single and double skipping pattern of exons 3 and 4.
We found that tc6 reduced the full-length CyPA mRNA by
98% at 0.2 mM concentration (Fig. 4).
Antisense activity of LNA-oligonucleotides
In order to compare the antisense ef®cacy of tc-DNA with that
of LNA, the same experiments were repeated with the LNA-
oligonucleotides lna1±4. A representative gel of the RT±PCR
products is given in Figure 5, and the corresponding data for
residual full-length CyPA mRNA were determined as before
(Fig. 6).
As in the case of tc-DNA, exon 3 skipping and exon 3+4
double skipping to about equal ratios was observed with lna3
and lna4 while no effect occurred with lna1 (9mer). Also here
nuclear antisense effects increased with increasing dose and
length of the oligonucleotides. However, full-length RNA was
only reduced to 69% with lna2 (11mer) at 0.2 mM concen-
tration. This indicates roughly a 5-fold less ef®cient splice
shifting compared to tc2. Interestingly, even with lna3 and
lna4 at 0.2 mM, 44 and 43%, respectively, of full length RNA
was still observed. This contrasts with the ef®cacy of the
tricyclo-backbone which reduced the amount of full-length
RNA to 11 and 0%, respectively. Furthermore, no increase in
nuclear antisense activity was observed between the 13mer
and 15mer LNA at 0.2 mM which indicated that the optimum
length/activity relation is already met at the level of a 13mer.
As in the case of tc-DNA, the selectivity of the antisense
response was investigated with the double mismatch sequence
lna5. With this oligonucleotide a full-length RNA production
of 88% relative to untreated controls was observed. Also here,
the antisense activity is not only dose- but also sequence-
dependent and reminiscent of a true antisense effect.
We also tested the ¯uorescently labeled oligonucleotide
lna6 for antisense activity. As with tc6, lna6 also showed
antisense activity with single and double exon skipping, but
again with less ef®ciency (64% remaining full-length RNA) as
compared to tc6. Thus in the cases investigated here, tricyclo-
oligonucleotides show stronger nuclear antisense effects than
corresponding lna-oligonucleotides by at least a factor of 4±5
although the overall af®nity of tc-DNA to an RNA target is
inferior to that of LNA.
Western blot
To ensure that exon skipping induced by tc-oligonucleotides
also led to a reduced CyPA protein level, a western blot was
performed. To this end, HeLa cells were transfected with tc4
(15mer) and left for 72 h before blotting. As can be seen from
Figure 7, CyPA protein is down-regulated in a concentration-
dependent manner. b-Actin was analyzed as a loading control.
At 0.1 mM concentration of tc4, only 45% of the normal CyPA
level was produced while at 0.2 mM, expression was reduced
to 13%. This experiment lends further evidence for tc-DNA
acting as speci®c and potent nuclear antisense oligonucle-
otides.
Cellular uptake and distribution
Given the surprisingly strong nuclear antisense effects, it was
of interest to follow the cellular uptake and distribution of the
tc- and lna-oligonucleotides. For this purpose we produced the
¯uorescently labeled oligonucleotide tc6 and lna6 (13mers)
targeting the 3¢-splice site upstream of exon 4. Free cellular
uptake by HeLa cells was investigated by ¯uorescence
microscopy via direct addition of a high concentration
(20 mM) of tc6 or lna6 to the cell culture. For both backbone
systems, we found no signi®cant ¯uorescence accumulation in
the cytosol or in the nucleus after 24 h of incubation. Only a
high background ¯uorescence associated with the cell mem-
brane was observed, indicating that no signi®cant internaliza-
tion occurred. A FACS analysis revealed a ®nal free
oligonucleotide uptake of only 3% in the case of tc6 and 0%
for lna6.
In a second experiment, we investigated the cellular
distribution of tc6 and lna6 24 h after lipofection at a
concentration of 0.2 mM (Fig. 8). We found some differences
in the cellular distribution of the two oligonucleotide
analogues. Tc-DNA (Fig. 8, left) is almost exclusively
Table 1. Oligonucleotides prepared and used in this study
Oligomer Sequence 5¢ ® 3¢a Target site (exon 4) Tm (°C)b ESI-MSc, calc. ESI-MSc, found
tc1 pCTTAC¢CACT* 5¢ss 56.4 3281.4 3282.9
tc2 pCCTTAC¢CACTC* 5¢ss 69.3 3935.8 3937.0
tc3 pCCCTTAC¢CACTCA 5¢ss 77.4 4388.2 4389.0
tc4 pACCCTTAC¢CACTCAG 5¢ss 83.2 5106.7 5107.6
tc5 pACCCTTAA¢CTCTCAG 5¢ss 60.2 5121.7 5121.5
tc6 pACCACC¢CTGTCAA-FAM 3¢ss ± 5035.0 5034.8
tcNS pCATTATTGCCCTGAAAGa ± ± 6210.2 6209.3
lna1 CTTAC¢CACT 5¢ss 82.6 2942.5 2941.0
lna2 CCTTAC¢CACTC 5¢ss »95 3605.3 3604.0
lna3 CCCTTAC¢CACTCA 5¢ss >95 4277.9 4276.2
lna4 ACCCTTAC¢CACTCAG 5¢ss >95 4976.3 4976.1
lna5 ACCCTTAA¢CTCTCAG 5¢ss 92.3 4977.3 4975.0
lna6 ACCACC¢CTGTCAA-FAM 3¢ss ± 4908.3 4907.0
aBold italic: mismatch position; C: 5-methylcytosine; a: 2¢-deoxyadenosine; (¢) denotes the splice position on the pre-mRNA; (*) denotes a 3¢-terminal
modi®cation by a 2,5-dimethoxytetrahydrofuran-3,4-diol unit (see Materials and Methods).
bTm values (2 mM duplex in 10 mM NaH2PO4, 150 mM NaCl, pH 7.0) were measured with the RNA complement r(ACUGAGUGGUAAGGGUA).
cMolecular masses were recorded in the negative ion mode and are indicated as [M-H]±.
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accumulated in the nucleus and virtually absent in the cytosol.
Within the nucleus, tc-DNA seems to be homogeneously
distributed with no obvious compartmentalization. The situ-
ation is somewhat different in the case of LNA (Fig. 8, right).
Also here, most of the oligonucleotide is localized in the
nucleus, although some ¯uorescence still remains in the
cytosol. Within the nucleus, LNA is unevenly distributed and
preferentially enriched in small bodies, most likely the
nucleoli.
DISCUSSION
Tc-DNA and LNA both belong to the class of conformation-
ally constrained DNA analogues. They share many common
features, such as the anionic nature of the backbone, increased
af®nity for RNA targets, overall A-like conformation in
duplexes with RNA, inability to activate RNaseH and
increased biostability (18,19,25). There are, however, differ-
ences in the relative dimensions of some of these features that
translate into different biological properties. For example, the
Figure 3. RT±PCR analysis of CyPA pre-mRNA splicing in HeLa cells in
the presence of varying concentrations (0.05, 0.1 and 0.2 mM) of antisense
tc-oligonucleotides (lanes 1±12). Lane 13 (control): RNA from untreated
cells.
Figure 4. Quantitative evaluation of full-length CyPA mRNA after
treatment with tc-oligonucleotides. Values are normalized averages of two
independent experiments. Control: RNA from untreated cells.
Figure 5. RT±PCR analysis of CyPA pre-mRNA splicing in HeLa cells in
the presence of varying concentrations (0.05, 0.1 and 0.2 mM) of antisense
lna-oligonucleotides (lanes 1±12). Lane 13 (control): RNA from untreated
cells.
Figure 6. Quantitative evaluation of full-length CyPA mRNA after
treatment with lna-oligonucleotides. All values are normalized averages
with standard deviations from three independent experiments. Control: RNA
from untreated cells.
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average increase in Tm of a modi®ed unit in RNA target
recognition relative to a DNA unit is between 4 and 7°C in the
case of LNA (17) and between 2 and 3°C in the case of tc-
DNA (19). The higher RNA af®nity of LNA relative to tc-
DNA is corroborated by the observed differences in the
thermal stabilities of LNA/RNA and tc-DNA/RNA duplexes,
where Tm differences of ca. 2.5±3.0°C per nucleotide unit
were found. Furthermore, tc-DNA possesses a sugar±phos-
phate backbone which is more hydrophobic due to the
extended carbon framework of the sugar unit. This might
affect cellular uptake and distribution. Moreover, there may
also be differences as to the extent of biostability against
nucleolytic activity of both backbone systems. In previous
experiments with tc-DNA we found a remarkable stability of
tc-DNA against snake venom phosphodiesterase (39) as well
as in heat deactivated fetal calf serum (25).
Tc- and lna-oligonucleotides with a length of 15 nt, used in
the submicromolar concentration range, can ef®ciently change
RNA maturation and largely abolish the production of the
associated protein in the cell. This goes along with no
signi®cant level of toxicity (measured in terms of cell number)
or alteration of cell morphology upon transfection.
Furthermore, we found that all antisense effects observed
were sequence-dependent, and thus true antisense effects. This
was demonstrated with the double mismatch oligonucleotides
which showed largely reduced antisense ef®cacy, and with a
nonsense 18mer tc-DNA which showed no antisense effect at
all. Remarkably, the differential increase in full-length RNA
production between tc4 and tc5 is higher (D = 70%) than in the
pair lna4 and lna5 (D = 45%). This indicates a slightly higher
selectivity of the tc-system in the antisense effect, compared to
LNA. With a sequence length of 15, genome-wide statistical
selectivity on the level of RNA is unlikely to be compromised.
Thus, strong binding oligonucleotide analogues such as tc-
DNA or LNA enable a reduction in the size of antisense
oligonucleotides, which for typical applications are 20±25 nt
in length. This could potentially reduce costs and material load
and increase selectivity.
According to the RT±PCR assays, tc-DNA shows increased
nuclear antisense effects by a factor of 4±5 or more, compared
to LNA. This contrasts with RNA target af®nity where LNA is
superior to tc-DNA. Thus there is an inverse af®nity/antisense
activity relation between the two systems. Differences in the
antisense response could in principle arise from different
cellular distribution patterns of the oligonucleotide systems.
LNA was previously found to occur in all compartments of
HeLa and other cells (20,24). In our experiments, we observed
some differences in the cellular distribution pattern of tc-DNA
and LNA. tc-DNA showed a higher propensity for nuclear
localization and a more homogeneous distribution within the
nucleus as compared to LNA (Fig. 8). This could be one
reason for the higher antisense ef®cacy of the former system.
Along the same lines, the observed accumulation of LNA
presumably in the nucleoli, the site of assembly of the
ribosomes, may competitively reduce its binding to the
spliceosome.
As a note of care, we add that the observed cellular
distribution could also be a property of the lipofectamine/
oligonucleotide complex and not a property of the oligonu-
cleotidic system alone. Thus we cannot exclude that the
distribution pattern changes when the nature of the cationic
lipid is varied. It was shown before in HeLa cells that 2¢-OMe
and 2¢-MOE-oligonucleotides have higher nuclear accumula-
tion when transfected with lipofectAMINE compared to when
scrape loaded (16). Also, we cannot exclude the possibility
that other effects, such as higher nuclease stability of tc-DNA,
also contribute to the observed higher ef®cacy of tc-DNA.
The fact that no signi®cant uptake was found for tc-
oligonucleotides applied at high doses but in the absence of
Figure 8. Fluorescence microscopic images of the cellular distribution of
tc6 (left) and lna6 (right) in HeLa cells (top: phase contrast image; center:
UV image; and bottom: overlay of both images).
Figure 7. Western blot, demonstrating the down-regulation of CyPA protein
by tc4. CyPA protein was probed with polyclonal anti-CyPA antibodies. A
polyclonal anti-actin antibody was used for loading control.
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transfecting agents is in line with observations on 2¢-O-alkyl
RNAs and also for LNA (24). However, we showed previously
that small amounts of tc-DNA, suf®cient to give weak
antisense effects, may still enter the cell under these condi-
tions (25). Nevertheless the increased hydrophobicity of the
tc-DNA backbone does not signi®cantly increase passive
penetration into cells. Ef®cient membrane passage is therefore
still a privilege of charge neutral DNA analogues such as
morpholino-DNA or cationic PNAs (16).
Interestingly, not only exon 4 is skipped, but also exon 3+4
double skipping occurs in spite of the fact that the
oligonucleotides were designed to bind exclusively to the
splice sites ¯anking exon 4. This fact seems to be neither
dependent on the oligonucleotide type used, as it occurs with
both LNA- and tc-oligonucleotides, nor is it dependent on the
length of the oligonucleotides. A sequence alignment revealed
no further binding site with nine or more matched base pairs in
the CyPA pre-mRNA (we note explicitly that neither of the
matched 9mers lna1 or tc1 showed a signi®cant antisense
effect). Furthermore, there is no difference in the splicing
pattern whether the 5¢- or the 3¢-splice site is targeted. Using
antisense U7 snRNAs targeting either exon 4 or exon 3 of
CyPA, the same phenomenon also occurs (D.SchuÈmperli and
co-workers, manuscript in preparation). Multiple exon skip-
ping was already observed before with antisense oligonucle-
otides or U7 snRNAs targeting exon 23 splice sites of the
mouse dystrophin gene (40,41). This implies that certain
groups of exons may be recognized by the splicing machinery
in a concerted fashion so that they tend to be coordinately
included in or excluded from the mRNA. However, the
mechanism for this is still unknown.
In summary, we have shown that tc-oligonucleotide 11±
15 mers, targeted to the 5¢-splice site of exon 4 ef®ciently
change the splice pattern of CyPA pre-mRNA. A direct
comparison with the analogous LNA-oligonucleotides re-
vealed a higher antisense ef®cacy of tc-DNA by at least a
factor of 4±5. Thus, tc-DNA emerges as a very powerful
nuclear antisense system. Whether tc-DNA is also useful for
cytosolic antisense applications has still to be shown.
Investigations in this direction with tc-DNA and tc-DNA±
DNA/tcDNA gapmers are currently under way in our labora-
tories.
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